Johnson & Johnson's gross profit for the
three
months ended in Dec. 2023 was $14,597 Mil. Johnson & Johnson's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was $61,532 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Johnson & Johnson's gross profit for the
three
months ended in Dec. 2023 was $14,597 Mil. Johnson & Johnson's Revenue for the
three
months ended in Dec. 2023 was $21,395 Mil. Therefore, Johnson & Johnson's Gross Margin % for the quarter that ended in Dec. 2023 was 68.23%.
Johnson & Johnson had a gross margin of 68.23% for the quarter that ended in Dec. 2023 => Durable competitive advantage
During the past 13 years, the highestGross Margin % of Johnson & Johnson was 70.28%. The lowest was 65.58%. And the median was 69.04%.
Johnson & Johnson Gross Profit Historical Data
The historical data trend for Johnson & Johnson's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Johnson & Johnson's Gross Profit
For the Drug Manufacturers - General subindustry, Johnson & Johnson's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson & Johnson's Gross Profit Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Gross Profit distribution charts can be found below:
* The bar in red indicates where Johnson & Johnson's Gross Profit falls into.
Johnson & Johnson Gross Profit Calculation
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
Johnson & Johnson's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $61,532 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
Johnson & Johnson's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Johnson & Johnson (NYSE:JNJ) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Johnson & Johnson had a gross margin of 68.23% for the quarter that ended in Dec. 2023 => Durable competitive advantage
Johnson & Johnson Gross Profit Related Terms
Thank you for viewing the detailed overview of Johnson & Johnson's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Johnson & Johnson (Johnson & Johnson) Business Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
JNJ has been successfully added to your 